Correlation Between Phoenix Biotech and Keyarch Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Phoenix Biotech and Keyarch Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phoenix Biotech and Keyarch Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phoenix Biotech Acquisition and Keyarch Acquisition, you can compare the effects of market volatilities on Phoenix Biotech and Keyarch Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phoenix Biotech with a short position of Keyarch Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phoenix Biotech and Keyarch Acquisition.

Diversification Opportunities for Phoenix Biotech and Keyarch Acquisition

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Phoenix and Keyarch is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Phoenix Biotech Acquisition and Keyarch Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keyarch Acquisition and Phoenix Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phoenix Biotech Acquisition are associated (or correlated) with Keyarch Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keyarch Acquisition has no effect on the direction of Phoenix Biotech i.e., Phoenix Biotech and Keyarch Acquisition go up and down completely randomly.

Pair Corralation between Phoenix Biotech and Keyarch Acquisition

If you would invest  1,154  in Keyarch Acquisition on September 13, 2024 and sell it today you would earn a total of  0.00  from holding Keyarch Acquisition or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Phoenix Biotech Acquisition  vs.  Keyarch Acquisition

 Performance 
       Timeline  
Phoenix Biotech Acqu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phoenix Biotech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Phoenix Biotech is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Keyarch Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Keyarch Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical indicators, Keyarch Acquisition is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Phoenix Biotech and Keyarch Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Phoenix Biotech and Keyarch Acquisition

The main advantage of trading using opposite Phoenix Biotech and Keyarch Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phoenix Biotech position performs unexpectedly, Keyarch Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keyarch Acquisition will offset losses from the drop in Keyarch Acquisition's long position.
The idea behind Phoenix Biotech Acquisition and Keyarch Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon